DSpace at VNU: Individual variations in arsenic metabolism in Vietnamese: the association with arsenic exposure and GSTP1 genetic polymorphism

View Article Online / Journal Homepage / Table of Contents for this issue Metallomics Dynamic Article Links Cite this: Metallomics, 2012, 4, 91–100 PAPER www.rsc.org/metallomics Downloaded on 28/04/2013 18:45:08 Published on 25 October 2011 on http://pubs.rsc.org | doi:10.1039/C1MT00133G Individual variations in arsenic metabolism in Vietnamese: the association with arsenic exposure and GSTP1 genetic polymorphism Tetsuro Agusa,a Takashi Kunito,b Nguyen Minh Tue,a Vi Thi Mai Lan,c Junko Fujihara,d Haruo Takeshita,d Tu Binh Minh,e Pham Thi Kim Trang,c Shin Takahashi,a Pham Hung Viet,c Shinsuke Tanabea and Hisato Iwata*a Received 16th August 2011, Accepted 29th September 2011 DOI: 10.1039/c1mt00133g We investigated the association of As exposure and genetic polymorphism in glutathione S-transferase p1 (GSTP1) with As metabolism in 190 local residents from the As contaminated groundwater areas in the Red River Delta, Vietnam Total As concentrations in groundwater ranged from o0.1 to 502 mg lÀ1 Concentrations of dimethylarsinic acid (DMAV), monomethylarsonic acid (MMAV), and arsenite (AsIII) in human urine were positively correlated with total As levels in the groundwater, suggesting that people in these areas may be exposed to As through the groundwater The concentration ratios of urinary AsIII/arsenate (AsV) and MMAV/inorganic As (IA; AsIII + AsV)(M/I), which are indicators of As metabolism, increased with the urinary As level Concentration and proportion of AsIII were high in the wild type of GSTP1 Ile105Val compared with the hetero type, and these trends were more pronounced in the higher As exposure group (456 mg lÀ1 creatinine in urine), but not in the lower exposure group In the high As exposure group, AsIII/AsV ratios in the urine of wild type of GSTP1 Ile105Val were significantly higher than those of the hetero type, while the opposite trend was observed for M/I These results suggest that the excretion and metabolism of IA may depend on both the As exposure level and the GSTP1 Ile105Val genotype Introduction It is well known that inorganic As (IA) is one of the human carcinogenic chemicals Contamination by naturally derived IA in groundwater has been reported in certain areas and has caused a large number of serious health issues.1–3 In such contaminated areas, skin pigmentation, hyperkeratosis, cancers, and resultant high mortalities have been caused by the chronic IA exposure in the local people.4–6 On the other hand, large differences in the sensitivity to IA-related diseases among individuals have been reported, suggesting its association with individual variations in IA metabolism.7 a Center for Marine Environmental Studies (CMES), Ehime University, Bunkyo-cho 2-5, Matsuyama 790-8577, Japan E-mail: iwatah@agr.ehime-u.ac.jp; Fax: +81-89-927-8172; Tel: +81-89-927-8172 b Department of Environmental Sciences, Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto 390-8621, Japan c Center for Environmental Technology and Sustainable Development (CETASD), Hanoi University of Science, Vietnam National University, T3 Building, 334 Nguyen Trai Street, Thanh Xuan District, Hanoi, Vietnam d Department of Legal Medicine, Shimane University Faculty of Medicine, Enya 89-1, Izumo 693-8501, Japan e Vietnam Environment Administration (VEA), Ministry of Natural Resources and Environment (MONRE), 273 Doi Can street, Ba Dinh, Hanoi, Vietnam This journal is c The Royal Society of Chemistry 2012 Ingested IA is metabolized to methylated arsenicals in the body and then mainly excreted through urine There are two hypotheses regarding IA metabolic pathways;8 oxidative methylation9,10 and reductive methylation.11,12 In these metabolic pathways, two enzymes, arsenic (+3 oxidation state) methyltransferase (AS3MT) and glutathione S-transferase o (GSTO), participate in the methylation and reduction of As compounds, respectively, in a variety of animals including the human.13 GSTs are a family of enzymes that play an important role in detoxification of various xenobiotics by catalyzing the conjugation of hydrophobic and electrophilic compounds with reduced glutathione There are seven classes of GSTs including a, m, o, p, y, s, and z GSTO1 is involved in the reduction activities of arsenate (AsV), monomethylarsonic acid (MMAV), and dimethylarsinic acid (DMAV).14–16 DMAV reductase activity of GSTO2 is much lower than that of GSTO1.17 Some researchers have reported the relevance of genetic polymorphisms of GSTO1 and O2 to As metabolism by in vitro assays 17–19 and in human studies.20–22 It has been suggested that GST p1 (GSTP1) plays a role in the reduction of IA toxicity An in vitro study using SA7 cells (As-resistant Chinese hamster ovary cells) revealed GSTP1 leveldependent resistance of IA.23 Zhou et al (2005) found that GSTP1 prevented IA-induced apoptosis in human lymphoma cell lines by reducing intracellular H2O2 levels.24 There are Metallomics, 2012, 4, 91–100 91 View Article Online Downloaded on 28/04/2013 18:45:08 Published on 25 October 2011 on http://pubs.rsc.org | doi:10.1039/C1MT00133G Table Associations of GSTP1 Ile105Val polymorphism with endpoints related to As Location Endpoint Association with genotype References West Bengal, India Bangladesh China Bangladesh Taiwan Taiwan Chile Vietnam Vietnam Skin lesion Skin lesion Skin lesion Skin lesion Atherosclerosis Bladder cancer Methylation of DMAV Methylation of IA AsV reduction No association No association High risk in Val type High risk in Val type High risk in Val type under high As exposure High risk in Ile type No association High in Ile/Val type High in Ile/Ile type 26 27 28 29 30 31 32 40 40 several single nucleotide polymorphisms (SNPs) in GSTP1 (http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?locusId = 2950) For the GST activity, the Ile (AA) type of GSTP1 Ile105Val (rs1695; A to G substitution at nucleotide base 6624 and isoleucine to valine substitution at amino acid base 105) was higher than the Val (GG) type in the erythrocyte.25 Several epidemiological studies have recently investigated the relationships between genetic polymorphisms in GSTP1 and IA-related diseases (Table 1), but the results were not consistent In the study in As-contaminated areas of West Bengal, no association of GSTP1 Ile105Val with skin lesion was observed.26 McCarty et al (2007) have reported that there was no significant difference in the genotype distribution of GSTP1 Ile105Val between Bangladeshi people with and without skin lesion.27 On the other hand, several studies have suggested that the Val type of GSTP1 Ile105Val was associated with increased risks of As-induced skin lesion in Chinese28 and Bangladeshi,29 and of atherosclerosis in Taiwanese.30 Wang et al (2007) also reported that the risk increased in Val type GSTP1 with high As exposure.30 However, Hsu et al (2008) evaluated the interaction of GSTP1 polymorphism with urinary transitional cell carcinoma in southwestern Taiwan and found that the Val type of GSTP1 Ile105Val showed a significantly lower cancer risk than the Ile type, suggesting that the wild type of GSTP1 Ile105Val may be sensitive to urinary transitional cell carcinoma.31 There are few studies evaluating whether GSTP1 Ile105Val polymorphism influences As metabolism Marcos et al (2006) revealed that the Val type had higher %DMAV than the Ile type, but it was not significant in Chilean.32 Since 2001, we have investigated As pollution in groundwater and its human exposure in Vietnam.8,33–43 Recently, we have focused on the association of genetic polymorphisms in As metabolic enzymes including GSTP1 with As metabolism and suggested that the heterozygote of GSTP1 Ile105Val had a higher metabolic capacity from IA to monomethyl As, while the opposite trend was observed for the metabolism from AsV to AsIII.40,41 However, the metabolic capacity of As has not been evaluated in association with GSTP1 Ile105Val polymorphisms and As exposure levels Inconsistent findings among previous studies on association of GSTP1 Ile105Val with As metabolic capacity as well as As-related diseases may partly result from the joint effects of human As exposure levels and genetic polymorphisms in GSTP1 The aim of this study is to clarify the association of As exposure and genetic polymorphism in GSTP1 Ile105Val with As metabolism as well as their co-interaction Therefore, we 92 Metallomics, 2012, 4, 91–100 analyzed concentrations of As compounds in the urine and genotyped GSTP1 Ile105Val in residents from As-contaminated groundwater areas in Vietnam Biological factors such as sex, age, body mass index (BMI), and habits of alcohol consumption and smoking were also incorporated to evaluate their contributions to individual variations in IA metabolism Materials and methods 2.1 Samples Samples of well water (n= 64) and human urine (n= 190) and blood (n= 190) were randomly collected from Hoa Hau (HH) and Liem Thuan (LT) in Ha Nam Province in March 200639 and from Thanh Vanh (TV) and THach Hoa (TH) in Ha Tay Province in September 2007 All communes are located in the rural area of the Red River Delta, Vietnam and there are no other significant sources of As such as mining sites or industries Several houses in HH, LT, and TV had wells equipped with a sand filter system and thus the sand-filtrated groundwater samples (n= 40) were also collected along with unfiltered water samples Usage period of the wells and their depth are shown in Table The informed consent was obtained from all the participants This study has been approved by the Ethical Committee of Ehime University, Japan Information on sex, age, residential years, body height and weight, body mass index (BMI), and smoking and alcohol habits of donors is summarized in Table All samples were kept at À25 1C in a freezer of the Environmental Specimen Bank (es-BANK) in Ehime University44 until chemical analyses and genotyping 2.2 Analyses of As Analytical methods for samples collected in 2006 have already been reported in our previous study.39 The methods of As analysis of water, and human urine and blood samples collected in 2007 were briefly summarized below After acidification with concentrated HNO3, total As (TA) in water samples was analyzed with an inductively coupled plasma-mass spectrometer (ICP-MS; HP-4500, Hewlett-Packard, Avondale, PA, USA) Rhodium was used as an internal standard to correct matrix effects and instrumental drift.39 Accuracy of the analytical method was confirmed in good agreement (91–95%) with certified TA concentration by analyzing a certified reference material, SLRS-4 River Water from the National Research Council Canada (NRCC) In addition, we have participated in an inter-calibration exercise program organized by the Swiss Federal Institute of This journal is c The Royal Society of Chemistry 2012 View Article Online Table Information on water and human samples from Hoa Hau (HH), Liem Thuan (LT), Thanh Vanh (TV), and Thach Hoa (TH) in Vietnam Downloaded on 28/04/2013 18:45:08 Published on 25 October 2011 on http://pubs.rsc.org | doi:10.1039/C1MT00133G Location Hoa Hau (HH) Liem Thuan (LT) Sampling season Mar-06 Mar-06 Groundwater No 15 13 (5.5–13) (1–16) Used period (years)a a Well depth (m) 14 (8–16) 15 (12–24) TA (mg lÀ1)b 368 (163–502, and 2120 (an outlier)) 1.4 (0.7–6.8) Filtered water No 10 18.9 (3.2–143) 2.0 (1.0–4.9) TA (mg lÀ1)b Drinking watere No 15 13 50.1 (3.2–486) 1.7 (0.9–4.9) TA (mg lÀ1)b Subjects No 51 49 No of male/female 22/29 22/27 Age (years)a 37 (11–60) 34 (11–70) Residential time (years)a 33 (3–60) 31 (6–65) a Height (cm) 156 (137–173) 150 (121–169) Weight (kg)a 48 (27–66) 44 (22–67) BMIa 20 (14–26) 19 (12–29) No of smoker/non-smoker 14/37 6/43 No of alcohol drinker/non-alcohol drinker 14/37 10/39 Urinary SA (mg g:1 creatinine)b 92.6 (45.2–365) 97.9 (38.6–397) Urinary AB (%)a 22.7 (4.0–56.8) 19.6 (3.1–58.6) V a Urinary DMA (%) 55.9 (32.6–77.2) 59.0 (29.1–78.9) V a Urinary MMA (%) 10.6 (2.9–17.8) 10.0 (4.8–20.9) Urinary AsIII (%)a 8.5 (0–20.3) 8.7 (0–19.8) Urinary AsV (%)a 2.3 (0–11.1) 2.7 (0–11.3) a Arithmetic mean and range b Geometric mean and range c Tukey–Kramer test instead of raw groundwater is assumed to be consumed Aquatic Science and Technology (Eawag) in the frame of the ongoing cooperation of Vietnam and Switzerland for As-related researches Concentration of TA in water samples is expressed in mg per l Urinary As compounds including arsenobetaine (AB), DMAV, MMAV, AsIII, and AsV were separated by a highperformance liquid chromatograph (HPLC; Shimadzu, LC10A Series, Kyoto, Japan) equipped with an Inertsil AS column (15 cm, 2.1 mm i.d.; GL Sciences Inc., Japan) The column was equilibrated with the mobile phase (10 mM sodium 1-butanesulfonate, mM tetramethylammonium hydroxide, mM malonic acid, and 0.5% methanol; pH 3.0 was adjusted with nitric acid) at a flow rate of 0.5 ml minÀ1 at 45 1C As internal standard, Rh was added into the buffer The injection volume was 10 ml Five arsenicals separated by the column were determined with ICP-MS Ion intensities at m/z 75 (75As), 77 (40Ar37Cl and 77Se), and 103 (103Rh) were monitored and there was no interference during HPLC/ICP-MS analysis A certified reference sample, NIES No 18 human urine that was provided by the National Institute for Environmental Studies (NIES), Japan, was analyzed to assure the methodological accuracy Analyzed concentrations of AB and DMAV were in good agreement with the certified values (90–106%) In the present study, sum of all As compounds, inorganic As (AsIII + AsV), and AsIII + AsV + MMAV + DMAV detected in urine sample are denoted as SA, IA, and IMDA, respectively Percentages of AB, AsIII, AsV, MMAV, DMAV, IA, and IMDA to SA in the human urine were denoted as %AB, %AsIII, %AsV, %MMAV, %DMAV, %IA, and %IMDA, respectively Urinary creatinine was determined at SRL, Inc (Tokyo, Japan) This journal is c The Royal Society of Chemistry 2012 d Thanh Vanh (TV) Thach Hoa (TH) p value Sep-07 Sep-07 21 (3–12) 38 (20–60) 36.0 (5.5–145) 15 (3–10) 33 (24–50) 0.1 (o0.1–0.5) 0.015c o0.001c o0.001c 21 5.4 (1.5–50.7) — o0.001c 21 5.4 (1.5–50.7) 15 0.1 (o0.1–0.5) o0.001c 50 21/29 32 (13–71) 30 (13–71) 155 (142–170) 46 (32–65) 19 (15–25) 8/42 13/37 63.5 (28.7–115) 16.0 (0–63.5) 51.8 (26.1–68.6) 11.5 (3.3–20.1) 9.7 (0–30.0) 11.0 (3.1–34.4) 40 21/19 35 (15–60) 17 (3–45) 158 (137–171) 52 (38–72) 21 (16–28) 7/33 13/27 43.2 (20.0–96.0) 28.3 (3.0–78.1) 44.4 (13.1–68.8) 7.2 (0–15.6) 6.6 (0–16.6) 13.5 (0–37.4) 40.05d 40.05c o0.001c o0.001c 0.001c 0.027c 40.05d 40.05d o0.001c 0.001c o0.001c o0.001c 0.013c o0.001c w2 test e In a house equipped with sand filter, filtered water and concentrations of As compounds in the urine were expressed as mg As per g on a creatinine basis Because AsV, IA, and MMAV are metabolized to AsIII, MMAV, and DMAV, respectively, in the human body, concentration ratios of AsIII/AsV (III/V), MMAV/ IA (M/I), and DMAV/MMAV (D/M) were used as an index for each metabolic process of AsV, IA, and MMAV 2.3 Genotyping of GSTP1 polymorphisms Genotyping of GSTP1 followed the methods described in our previous study.40 A QIAamp DNA mini kit (Qiagen, Chatworth, CA) was used to extract DNA from whole blood sample The reference sequence of GSTP1 (accession number, AY324387) was based on the DNA Data Bank of Japan (DDBJ) Forward and reverse primers of GSTP1 Ile105Val were -ACCCCAGGGCTCTATGGGAA-30 and 50 -TGAGGGCACAAGAAGCCCCT-3 , respectively DNA was amplified with PCR in a 10 ml reaction mixture containing GoTaqs Green Master Mix (Promega, Madison WI, USA) at 55 1C of annealing temperature and then treated with Bsm AI at 37 1C The PCR products were separated in 8% polyacrylamide gel by electrophoresis (300 V, 15 min) and were detected by silver staining The genotyping was carried out in duplicate The representativeness of nucleotide sequences for the genotype was confirmed with a Genetic Analyzer (model 310, Applied Biosystems) 2.4 Statistical analyses Together with the data in the present study, analytical data in the water and human urine from HH and TL provided in our previous study39,40 were used for statistical analyses StatView Metallomics, 2012, 4, 91–100 93 Downloaded on 28/04/2013 18:45:08 Published on 25 October 2011 on http://pubs.rsc.org | doi:10.1039/C1MT00133G View Article Online (version 5.0, SASs Institute, Cary, NC, USA), PASW Statistics (v 18.0J, SPSS Inc., Chicago, IL, USA), and EXCEL Toukei (Version 6.05, Esumi Co., Ltd., Tokyo, Japan) were used for the statistical analyses One half of the value of the respective limits of detection was substituted for those values below the limits of detection and used in the statistical analysis Normality of the distribution of all variables was checked by Kolmogorov– Smirnov’s one sample test To adapt parametric analyses, the data, which showed non-normal distribution, were log-transformed Student’s t-test and the Tukey–Kramer test were conducted to find differences in As levels and compositions in human urine among locations and the genotype of GSTP1 A w2 test was employed for checking sample size distribution in each group category Relationships between variables were assessed by the Pearson correlation coefficient To assess the factors affecting As levels in the urine and metabolic capacity of As, a stepwise multiple regression analysis was executed In the regression models, nominal variables such as As exposure status, sex, alcohol and smoking habits, and genotype of GSTP1 Ile105Val were transformed to dummy variables (0 and 1) The multicollinearity of independent variables was assessed by calculating the variance inflation factor (VIF) po 0.05 was considered to be statistically significant Results and discussion Concentration of TA in groundwater Concentrations of TA in groundwater are shown in Table The range of concentration was o0.1–502 mg lÀ1 (one sample that had 2120 mg lÀ1 was regarded as an outlier and removed from further statistical analysis because the water had large amounts of particles) A significant regional difference in TA concentration was observed; HH (geometric mean (GM), 368 mg lÀ1) TV (GM, 36.0 mg lÀ1) LT (GM, 1.4 mg lÀ1) TH (GM, 0.1 mg lÀ1) (po 0.001) 54.7% of all groundwater samples exceeded the drinking water guideline (10 mg lÀ1) established by WHO.5 Remarkably, 100% and 95.2% of groundwater samples from HH and TV had TA concentration over the guideline value.5 These results indicate that groundwaters from HH and TV are not suitable for drinking Analyses of relationships between TA concentration and well depth showed a significant positive correlation in the groundwater from TV (r= 0.693, p= 0.003), indicating that the concentration of TA may be higher in the deeper layer of the aquifer in TV Several residents have consumed sand-filtered groundwater in these sampling areas except in TH Concentrations of TA in the filtered water were in the range of 1.0–143 mg lÀ1 (Table 2) There was a significant (po 0.001) regional difference in TA concentrations in the filtered water; HH (GM, 18.9 mg lÀ1) TV (GM, 5.4 mg lÀ1) LT (GM, 2.0 mg lÀ1) Through the sand filtration, TA concentrations in the raw groundwater from HH and TV significantly reduced (po 0.001) and the removal efficiencies were 93% in HH and 82% in TV on arithmetic mean (AM) (Fig 1) However, 80% and 29% of filtered-water samples from HH and TV were still higher than the WHO guideline value.5 This result suggests that safe drinking water is not always obtained by only a sand filter 94 Metallomics, 2012, 4, 91–100 Fig Concentrations of TAs in raw and sand-filtrated groundwater from Hoa Hau (HH), Thanh Vanh (TV), and Liem Thuan (LT) in Vietnam Bar indicates each concentration of TA in raw and sand-filtered groundwater system and thus, further removal techniques of As from groundwater are required in highly As-contaminated groundwater areas To evaluate the As exposure status of the residents, we considered the well water, which local people are drinking, as the major source of As Concentration of TA in drinking water was regarded as those in raw groundwater for the houses without a sand-filter system, and as those in filtered water for the houses with the filter system Concentrations of TA in drinking water from HH, TV, LT, and TH are shown in Table The highest As concentration in drinking water was observed in HH (GM, 50.1 mg lÀ1), followed by TV (GM, 5.4 mg lÀ1), LT (GM, 1.7 mg lÀ1), and TH (GM, 0.1 mg lÀ1) and a significant difference was detected among all the four locations (po 0.001) In HH and TV, samples with TA concentrations exceeding the guideline value for drinking water5 were 88% and 29%, respectively Considered that As concentration in the drinking water represents close to the real exposure status in local residents, potential health risk of people drinking those As-contaminated water is of great concern Concentration and composition of As compounds in human urine Concentrations of SA and composition of As compounds in the urine of people from HH, TV, TL, and TH are summarized in Table Urinary As was detected in all samples and the range of urinary SA concentrations was from 20.0 to 397 mg gÀ1 creatinine To understand the exposure level of As in local people through drinking water, relationships between As concentrations in drinking water and human urine were assessed As shown in Fig 2, concentrations of DMAV (R2 = 0.118, po 0.001), MMAV (R2 = 0.141, po 0.001), and AsIII (R2 = 0.068, po 0.001) in human urine were positively correlated with that of TA in drinking water Significant positive correlations between concentrations of TA in drinking water and urinary AsV (R2 = 0.028, p = 0.036), IMDA (R2 = 0.114, po 0.001), and SA (R2 = 0.088, po 0.001) were also observed (data not shown) These results suggest that the residents in these areas are exposed to As through the consumption of drinking water and ingested This journal is c The Royal Society of Chemistry 2012 View Article Online largely different from Africans, Europeans, and Americans (0.448–0.701 for A allele frequencies) Downloaded on 28/04/2013 18:45:08 Published on 25 October 2011 on http://pubs.rsc.org | doi:10.1039/C1MT00133G Factors influencing As concentration and metabolism in humans Fig Relationships between concentrations of TA in drinking water and As compounds (DMAV, MMAV, AsIII, and AB) in human urine from Hoa Hau (HH), Thanh Vanh (TV), Liem Thuan (LT), and Thach Hoa (TH) in Vietnam Dashed line indicates WHO guideline value (10 mg lÀ1) for drinking water (WHO, 2004) As are metabolized to MMAV and DMAV in the body On the other hand, concentration of urinary AB, which is probably derived from fish and shellfish ingestion, showed no association with the TA level in drinking water (p4 0.05) (Fig 2) Among the As compounds detected, DMAV (AM, 53%) was the most predominant species, followed by AB (AM, 21%), MMAV (AM, 10%), AsIII (AM, 8%), and AsV (AM, 7%) Because As compounds are transformed by reduction and methylation processes in the human body,9–12 concentration ratios of AsIII/AsV (III/V), MMAV/IA (M/I), and DMAV/MMAV (D/M) in human urine were defined as metabolic indices for the reduction, first methylation, and second methylation, respectively In the present study, GM for III/V, M/I, and D/M were 1.2, 0.7, and 5.4, respectively Genotype distribution of GSTP1 Ile105Val Genotyping results of GSTP1 Ile105Val showed no mutation of the homo type (Val/Val) in this population Genotype frequency in all donors was 0.68 for AA (Ile/Ile) and 0.32 for AG (Ile/Val), whereas A and G allele frequencies were 0.84 and 0.16, respectively However, the GSTP1 Ile105Val genotype did not follow the Hardy–Weinberg principle in this study (p= 0.010) Although the reason remains unclear, we could confirm no genotyping error by conducting duplicate analyses of all DNA samples and by sequence analyses of some representative samples Compared with the allele frequency of GSTP1 Ile105Val in 11 populations published in the HapMap database (HapMap Data Rel 28 PhaseII +III, August 10, on NBCI B36 assembly, dvSNP b 126; http://hapmap.ncbi.nlm nih.gov/cgi-perl/snp_details_phase3?name = rs1695&source = hapmap28_B36&tmpl = snp_details_phase3), the A allele frequency (0.84) in Vietnamese detected in this study was similar to those in Chinese populations (0.816 in Han Chinese in Beijing, China groups (CHB (H)) and 0.812 in Chinese in Metropolitan Denver, Colorado (CHD (D)) On the contrary, allele distribution in Vietnamese in the present study was This journal is c The Royal Society of Chemistry 2012 To understand which factors can affect the concentration of As and its metabolic capacity, a stepwise multiple regression analysis was performed As potential factors, As exposure status, genotype of GSTP1 Ile105Val, sex, age, BMI, alcohol consumption, and smoking habit were taken into consideration Before the analyses, the As exposure level was defined by dividing all donors into two categories, high (HA) and low (LA) As exposure groups, based on GM for urinary IMD concentration (56 mg gÀ1 creatinine) No significant bias in sample numbers among As exposure level, genotype of GSTP1 Ile105Val, and sex was validated by a w2 test Sex ratios were significantly different in both smoking and alcohol habits, because only a few females had these habits The calculated VIF values of explanatory variables were less than 10, and thus multi-collinearity in the multiple regression analysis was rejected Results of the multiple regression analyses are listed in Table When all donors were evaluated, As exposure level, genotype of GSTP1 Ile105Val, sex, and BMI were significantly correlated with urinary As concentration and metabolic capacity, with the influence of exposure status being the strongest These results were similar to our previous study.40 Remarkably, the exposure level of As was significantly associated with not only urinary concentrations of As compounds as expected, but also metabolic indices except for D/M Indicators of As metabolism such as %DMAV, %MMAV, %AsIII, %IMDA, III/V, and M/I of HA were higher than those of LA, while the opposite results were observed for %AB, %AsV, and %IA (Table 3) Comparisons of III/V and M/I between HA and LA are shown in Fig These results indicate that the metabolism from AsV to AsIII and from IA to MMAV may be facilitated by high As exposure level No significant increase in D/M with the As exposure level implies that 2nd methylation may not be facilitated by high exposure Although decreased %AB could be explained by increased %DMAV, %MMAV, and %IA with As exposure, it was not clear why higher concentration of urinary AB was observed In all participants, GSTP1 Ile105Val was associated with III/V, M/I, and concentrations of AB, AsIII, IA, IMDA, and SA Negative correlations between BMI and concentrations of MMAV, AsV, IA, and IMDA in human urine were observed Females had higher %DMAV and D/M than males Because it was found that the As exposure status significantly influenced many parameters (Table 3), we repeated the stepwise regression analysis by dividing all donors into HA and LA to better understand the difference in factors associated with As excretion and metabolic capacity between those groups (Table 4) Interestingly, it was found that the factors, which could relate to As concentration and metabolism, were different between HA and LA except relationships between sex and D/M (Table 4); D/M in females was significantly higher than that in males regardless of the As exposure level, suggesting a higher methylation capacity from MMAV to DMAV in females Metallomics, 2012, 4, 91–100 95 View Article Online Table Stepwise multiple regression analysis of As concentrations and compositions in urine against sexa, age, BMI, alcohol and smoking habitsa, As exposure level, and polymorphism of GSTP1 Ile105Vala Dependent variable R2adj p %AB %DMAV Downloaded on 28/04/2013 18:45:08 Published on 25 October 2011 on http://pubs.rsc.org | doi:10.1039/C1MT00133G %MMAV %AsIII %As V %IA M/I D/M a b Exposure (0 = low, = high) À0.193 0.015 p AB 0.094 o0.001 Exposure 0.287 o0.001 DMAV (0 = low, = high) Sex (0 = female, = male) À0.158 0.039 0.028 0.021 Exposure 0.183 0.021 MMAV (0 = low, = high) 0.016 0.045 Exposure (0 = low, = high) 0.080 o0.001 Exposure (0 = low, = high) 0.025 0.026 %IMDA III/V 0.031 0.015 Dependent variable R2adj p Independent variable 0.031 0.015 0.146 0.045 AsIII À0.293 o0.001 As V Exposure (0 = low, = high) À0.177 Exposure (0 = low, = high) 0.193 0.026 IA 0.015 IMDA 0.196 o0.001 Exposure 0.402 o0.001 SA (0 = low, = high) GSTP1 Ile105Val À0.183 0.019 (0 = Ile/Ile, = Ile/Val) 0.144 o0.001 Exposure 0.370 o0.001 (0 = low, = high) GSTP1 Ile105Val 0.159 0.021 (0 = Ile/Ile, = Ile/Val) 0.057 o0.001 Sex (0 = female, = male) À0.250 o0.001 Independent variable 0.085 o0.001 Exposure (0 = low, = high) GSTP1 Ile105Val (0 = Ile/Ile, = Ile/Val) 0.564 o0.001 Exposure (0 = low, = high) 0.410 o0.001 Exposure (0 = low, = high) BMI 0.258 o0.001 Exposure (0 = low, = high) GSTP1 Ile105Val (0 = Ile/Ile, = Ile/Val) 0.039 0.009 BMI Exposure (0 = low, = high) 0.250 o0.001 Exposure (0 = low, = high) GSTP1 Ile105Val (0 = Ile/Ile, = Ile/Val) BMI 0.627 o0.001 Exposure (0 = low, = high) BMI GSTP1 Ile105Val (0 = Ile/Ile, = Ile/Val) 0.510 o0.001 Exposure (0 = low, = high) GSTP1 Ile105Val (0 = Ile/Ile, = Ile/Val) b p 0.254 o0.001 À0.156 0.027 0.753 o0.001 0.613 o0.001 À0.141 0.013 0.472 o0.001 À0.173 0.007 À0.188 0.010 À0.143 0.049 0.393 o0.001 À0.217 o0.001 À0.176 0.006 0.757 o0.001 À0.123 À0.104 0.007 0.021 0.693 o0.001 À0.139 0.007 These nominal variables were transformed to dummy variables (0 or 1) Fig Comparison of III/V and M/I between low (LA) and high As (HA) exposure groups from Hoa Hau (HH), Thanh Vanh (TV), Liem Thuan (LT), and Thach Hoa (TH) in Vietnam Data are given as geometric mean and geometric standard deviation *** indicates statistical significance at p o 0.001 regardless of the As exposure level It has been reported that the 2nd methylation capacity is higher in females than in males in most studies.39,45 Our results support these previous reports The present study also showed that %MMAV in males was significantly higher compared with females in HA A similar trend was observed for %AsV in LA, although the significant level was weak The sexual difference in methylation capacity 96 Metallomics, 2012, 4, 91–100 may be partly associated with an estrogen-related metabolic pathway.45 The mechanism of sexual difference in As metabolism needs more attention in future studies The GSTP1 Ile105Val hetero type had lower concentrations of AsIII, IA, and IMDA, and III/V and higher M/I than the wild type in HA, but not in LA (Table 4) For urinary concentration of AsIII (Fig 4), it is suggested that the GSTP1 genotype may be linked with the excretion of AsIII into the urine Leslie et al (2004) investigated a transport mechanism of AsIII by a multidrug resistance protein (MRP1/ABCC1) using a specific cell line, H69AR over-expressing MRP1 and found that MRP1 can transport AsIII only in the presence of GSH and expression of GSTP1 in the plasma membrane is required for the transportation of AsIII(+GSH).46 Zhong et al (2006) reported that in the erythrocyte of the healthy Chinese, the GSTP1 Ile105Val wild type showed a higher catalytic activity than the mutation type.25 Considering these reports together, in the higher As exposure group, the GSTP1 Ile105Val wild type might accelerate the conjugation of GSH to AsIII more than the mutation type and the conjugate may be more efficiently excreted from the cell through the MRP1 transporter Further in vivo and human case studies are needed to verify this hypothesis This journal is c The Royal Society of Chemistry 2012 View Article Online Table Stepwise multiple regression analysis of As concentrations and compositions in urine against sexa, age, BMI, alcohol and smoking habitsa, As exposure statusa, and polymorphism of GSTP1 Ile105Vala for each As exposure level Dependent variable R2adj p Independent variable b p High As exposure Downloaded on 28/04/2013 18:45:08 Published on 25 October 2011 on http://pubs.rsc.org | doi:10.1039/C1MT00133G %MMAV %AsIII Dependent variable R2adj p DMAV 0.085 0.057 0.009 Sex (0 = female, = male) 0.258 0.009 MMAV 0.066 0.006 GSTP1 Ile105Val À0.274 0.006 AsIII (0 = Ile/Ile, = Ile/Val) IA %IMDA IMDA 0.068 0.019 GSTP1 Ile105Val À0.287 0.019 SA (0 = Ile/Ile, = Ile/Val) M/I 0.121 0.001 Age 0.264 0.007 GSTP1 Ile105Val 0.249 0.010 (0 = Ile/Ile, = Ile/Val) D/M 0.042 0.024 Sex (0 = female, = male) À0.227 0.024 Low As exposure AB III/V V %DMA %AsV %IA D/M a 0.066 0.035 0.038 0.133 0.008 0.044 0.038 0.001 Sex (0 = female, = male) À0.277 0.008 DMA Sex (0 = female, = male) 0.214 0.044 BMI À0.220 0.038 Sex (0 = female, = male) À0.298 0.004 Age 0.265 0.011 0.057 b p À0.397 0.252 0.005 BMI Age 0.048 0.016 BMI 0.126 o0.001 GSTP1 (0 = Ile/Ile, = Ile/Val) 0.179 o0.001 GSTP1 Ile105Val (0 = Ile/Ile, = Ile/Val) BMI 0.160 o0.001 BMI GSTP1 Ile105Val (0 = Ile/Ile, = Ile/Val) Age 0.051 0.014 BMI 0.054 V Independent variable 0.001 0.037 À0.240 0.016 À0.367 o0.001 À0.377 o0.001 À0.235 0.011 À0.455 o0.001 À0.242 0.010 0.251 À0.245 0.031 0.014 0.016 GSTP1 Ile105Val À0.255 (0 = Ile/Ile, = Ile/Val) 0.013 Sex (0 = female, = male) À0.261 0.016 0.013 These nominal variables were transformed to dummy variables (0 or 1) Fig Comparison of AsIII concentration between the wild and hetero types of GSTP1 Ile105Val among all participants, and high (HA) and low As (LA) exposure groups from Hoa Hau (HH), Thanh Vanh (TV), Liem Thuan (LT), and Thach Hoa (TH) in Vietnam Data are given as geometric mean and geometric standard deviation ** and *** indicate statistical significance at po 0.01 and po 0.001, respectively A lower III/V in the hetero type of GSTP1 Ile105Val than the wild type in all participants and HA (Table and 4, and Fig 5) suggest that the heterozygote of GSTP1 Ile105Val might have a lower reduction capacity from AsV to AsIII and this reduction capacity may depend on the As exposure level Although the reductase activity of AsV by GSTP1 was not measured, the wild GSTP1 Ile105Val protein has a high catalytic GST activity compared with the mutation type.25 The hetero type of GSTP1 Ile105Val had higher M/I than the wild type in all participants and HA (Fig 5) This result may be associated with the capacity of As transport from cells, This journal is c The Royal Society of Chemistry 2012 Fig Comparison of III/V and M/I between the wild and hetero types of GSTP1 Ile105Val among all participants, and high (HA) and low As (LA) exposure groups from Hoa Hau (HH), Thanh Vanh (TV), Liem Thuan (LT), and Thach Hoa (TH) in Vietnam Data are given as geometric mean and geometric standard deviation * and ** indicate statistical significance at po 0.05 and po 0.01, respectively because GSTP1 has no function of As methylation Considering that the GSTP1 Ile105Val hetero type may have less function to Metallomics, 2012, 4, 91–100 97 Downloaded on 28/04/2013 18:45:08 Published on 25 October 2011 on http://pubs.rsc.org | doi:10.1039/C1MT00133G View Article Online excrete AsIII (IA) (Fig 4), the pathway of methylation from IA to MMAV might be more dominant than the excretion in the hetero type In addition, this may be more likely when people are exposed to high As In the copper mine workers from Chile, %DMAV in the Val type of GSTP1 Ile105Val was higher than that in the Ile type, although the result was not statistically significant32 (Table 1) Similarly, this study revealed no association of %DMAV in the GSTP1 Ile105Val genotype BMI has been used as an indicator of nutritional status or obesity By using the stepwise regression analyses, BMI had negative correlations with DMAV, MMAV, IA, IMDA, and SA concentrations in HA (Table 4) These results suggest two hypotheses; the exacerbation of nutritional status by As exposure and the effect of increased body fat on As accumulation in the high As exposure group Similar results were obtained in Vietnam in our previous studies.39,40 Other studies47–50 have reported the interaction between BMI and metabolic capacity of As, which was not observed in our studies In the present study, a negative correlation between BMI and %IA was found only in LA Increased %DMAV and decreased %MMAV with an increase in BMI in local residents were reported from blackfoot disease-hyperendemic areas in Taiwan47 and in European males.48 On the other hand, there are some contradictory reports, indicating no significant association of BMI with As metabolism.49,50 Age was positively correlated with M/I and concentrations of DMAV and IMDA only in HA (Table 4) Similar findings were reported in Vietnamese.39,40 Kurttio et al (1998) found a slight increase of DMAV with age in adults from Finland.51 In a study of Argentina, %IA decreased with age, but there were no age-dependent variations in %MMAV, %DMAV, and D/M.52 It has been suggested that children may have a higher 2nd methylation capacity compared to adults.37,53,54 However, no clear associations were detected between age and urinary D/M or %DMAV in the present study, probably due to small sample size of children (n= 21 for o 15 years old) One should notice that adjusted determination coefficients (R2adj) in the multiple regression equations were moderate (0.016–0.627), even though the p values were less than 0.001 This suggests that there are other factors that are involved in As concentration and metabolism of the participants Genetic polymorphisms of other As metabolic enzymes such as AS3MT8,39,40,41 and methylenetetrahydrofolate reductase (MTHFR)48,52,55 may be one of the potential factors In addition, several SNPs are known in MRP1.56 Further studies are necessary to assess potential effects of these genetic variations on the metabolism and toxicity of As Conclusions This study revealed that both environmental (As exposure status) and genetic factors (GSTP1 Ile105Val polymorphism) are significantly associated with the concentration and metabolism of As in humans Furthermore, it can be suggested that the association of GSTP1 Ile105Val polymorphism with As is enhanced under high As exposure This means that it can be important when association of genetic polymorphisms in As metabolic enzymes is evaluated in some populations 98 Metallomics, 2012, 4, 91–100 Fig Suspected pathways of As metabolism and excretion by GSTP1 Ile105Val polymorphism Solid and dashed arrows indicate strong and weak pathways, respectively A proposed mechanism of As metabolism and excretion by GSTP1 Ile105Val is summarized in Fig The wild type (Ile type) of GSTP1 Ile105Val may have a high reductive capacity from AsV to AsIII GSTP1 may conjugate GSH to AsIII on the membrane and then AsIII-GS may be excreted through MRP1 Since the GSTP1 Ile105Val wild type may have a higher activity than the hetero type, the wild type may efficiently excrete AsIII-GSH compared with the hetero type On the contrary, the hetero type (Val type) of GSTP1 Ile105Val may have a relatively lower reduction activity and excretion and thus the metabolism to MMAV may be more facilitated These pathways may be accelerated with an increase in the As exposure status in humans To verify these hypotheses, further studies are required to determine (i) whether GSTP1 can reduce from AsIII to AsV like GSTO1; (ii) whether GSTP1 can facilitate excretion of AsIII through MRP1; (iii) whether these functions vary among the GSTP1 Ile105Val genotype; and (iv) whether interaction of GSTP1 polymorphism with As excretion and metabolism is influenced by the As exposure level Abbreviations AB AS3MT As AsIII AsV BMI D/M DMAV Eawag GST GSTO1 GSTO2 GSTP1 HA HH HPLC IA ICP-MS III/V IMDA LA LT arsenobetaine As (+3 oxidation state) methyltransferase arsenic arsenite arsenate body mass index DMAV/MMAV dimethylarsinic acid Swiss Federal Institute of Aquatic Science and Technology glutathione-S-transferase glutathione-S-transferase o glutathione-S-transferase o glutathione-S-transferase p high As exposure group Hoa Hau high performance liquid chromatograph inorganic As Here, As[V] + As[III] inductively coupled plasma mass spectrometer AsIII/AsV AsIII + AsV + MMAV + DMAV low As exposure group Liem Thuan This journal is c The Royal Society of Chemistry 2012 View Article Online Downloaded on 28/04/2013 18:45:08 Published on 25 October 2011 on http://pubs.rsc.org | doi:10.1039/C1MT00133G M/I MMAV MRP1 MTHFR NRCC PCR-RFLP SNP TA TH TV VIF MMAV/IA monomethylarsonic acid multidrug resistance protein methylenetetrahydrofolate reductase National Research Council Canada PCR restriction fragment length polymorphism single nucleotide polymorphism total As Thach Hoa Thanh Vanh variance inflation factor Acknowledgements We wish to thank Dr A Subramanian, CMES, Ehime University, Japan for critical reading of the manuscript The authors express their thankfulness to the staff of the CETASD, Hanoi University of Science and Dr H Sakai (current affiliation; Department of Pharmacology, Yamaguchi University Graduate School of Medicine, Japan), Dr D Imaeda (current affiliation; IDEA Consultants, Inc.), and Ms H Mizukawa from CMES for their help in sample collection We also acknowledge Ms H Touma, Ms N Tsunehiro, and Dr Ogawa, staff of the esBANK, CMES for their support in sample management and Ms Y Fujii, Department of Legal Medicine, Shimane University Faculty of Medicine, Japan for her technical assistance This study was supported by Japan Society for the Promotion of Science (JSPS) for the cooperative research program under the Core University Program between JSPS and Vietnamese Academy of Science and Technology (VAST) Financial support was also provided by grants from Research Revolution 2002 (RR2002) Project for Sustainable Coexistence of Human, Nature and the Earth (FY2002), Grants-in-Aid for Scientific Research (S) (No 20221003 and 21221004) and (A) (No 19209025) from JSPS, and 21st Century and Global COE Programs from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan and JSPS The award of the JSPS Post Doctoral Fellowship for Researchers in Japan to T Agusa (No 207871) is also acknowledged References B K Mandal and K T Suzuki, Arsenic round the world: a review, Talanta, 2002, 58, 201–235 D K Nordstrom, Public health Worldwide occurrences of arsenic in ground water, Science, 2002, 296, 2143–2145 P L Smedley and D G Kinniburgh, A review of the source, behaviour and distribution of arsenic in natural waters, Appl Geochem., 2002, 17, 517–568 M Tondel, M Rahman, A Magnuson, I A Chowdhury, M H Faruquee and S A Ahmad, The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh, Environ Health Perspect., 1999, 107, 727–729 WHO, Guidelines for Drinking Water Quality, World Health Organization, Geneva, Switzerland, 3rd edn, 2004 M M Wu, T L Kuo, Y H Hwang and C J Chen, Dose– response relation between arsenic concentration in well water and mortality from cancers and vascular diseases, Am J Epidemiol., 1989, 130, 1123–1132 M Vahter, Mechanisms of arsenic biotransformation, Toxicology, 2001, 164, 17 T Agusa, J Fujihara, H Takeshita and H Iwata, Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms, Int J Mol Sci., 2011, 12, 2351–2382 This journal is c The Royal Society of Chemistry 2012 F Challenger, Biological methylation, Chem Rev., 1945, 36, 315–361 10 W R Cullen and K J Reimer, Arsenic speciation in the environment, Chem Rev., 1989, 89, 713–764 11 T Hayakawa, Y Kobayashi, X Cui and S Hirano, A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19, Arch Toxicol., 2005, 79, 183–191 12 H Naranmandura, N Suzuki and K T Suzuki, Trivalent arsenicals are bound to proteins during reductive methylation, Chem Res Toxicol., 2006, 19, 1010–1018 13 H V Aposhian and M M Aposhian, Arsenic toxicology: five questions, Chem Res Toxicol., 2006, 19, 1–15 14 R A Zakharyan and H V Aposhian, Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase, Chem Res Toxicol., 1999, 12, 1278–1283 15 R A Zakharyan, A Sampayo-Reyes, S M Healy, G Tsaprailis, P G Board, D C Liebler and H V Aposhian, Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily, Chem Res Toxicol., 2001, 14, 1051–1057 16 R A Zakharyan, G Tsaprailis, U K Chowdhury, A Hernandez and H V Aposhian, Interactions of sodium selenite, glutathione, arsenic species, and omega class human glutathione transferase, Chem Res Toxicol., 2005, 18, 1287–1295 17 E M Schmuck, P G Board, A K Whitbread, N Tetlow, J A Cavanaugh, A C Blackburn and A Masoumi, Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer’s and Parkinson’s diseases, Pharmacogenet Genomics, 2005, 15, 493–501 18 T Tanaka-Kagawa, H Jinno, T Hasegawa, Y Makino, Y Seko, N Hanioka and M Ando, Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn), Biochem Biophys Res Commun., 2003, 301, 516–520 19 (a) A K Whitbread, N Tetlow, H J Eyre, G R Sutherland and P G Board, Characterization of the human Omega class glutathione transferase genes and associated polymorphisms, Pharmacogenetics, 2003, 13, 131–144, DOI: 10.1097/01.fpc.0000054062.98065.6e 20 L L Marnell, G G Garcia-Vargas, U K Chowdhury, R A Zakharyan, B Walsh, M D Avram, M J Kopplin, M E Cebrian, E K Silbergeld and H V Aposhian, Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles, Chem Res Toxicol., 2003, 16, 1507–1513 21 M M Meza, L Yu, Y Y Rodriguez, M Guild, D Thompson, A J Gandolfi and W T Klimecki, Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children, Environ Health Perspect., 2005, 113, 775–781 22 L Paiva, R Marcos, A Creus, M Coggan, A J Oakley and P G Board, Polymorphism of glutathione transferase Omega in a population exposed to a high environmental arsenic burden, Pharmacogenet Genomics, 2008, 18, 1–10 23 J F Lo, H F Wang, M F Tam and T C Lee, Glutathione S-transferase pai in an arsenic-resistant Chinese hamster ovary cell line, Biochem J., 1992, 288, 977–982 24 L Zhou, Y Jing, M Styblo, Z Chen and S Waxman, Glutathione-S-transferase inhibits As2O3 induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolism, Blood, 2005, 105, 1198–1203 25 S L Zhong, S F Zhou, X Chen, S Y Chan, E Chan, K Y Ng, W Duan and M Huang, Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese, Eur J Pharm Sci., 2006, 28, 77–85 26 P Ghosh, A Basu, J Mahata, S Basu, M Sengupta, J K Das, A Mukherjee, A K Sarkar, L Mondal, K Ray and A K Giri, Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water, Int J Cancer, 2006, 118, 2470–2478, DOI: 10.1002/ijc.21640 27 K M McCarty, Y C Chen, Q Quamruzzaman, M Rahman, G Mahiuddin, Y M Hsueh, L Su, T Smith, L Ryan and D C Christiani, Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions, Environ Health Perspect., 2007, 115, 341–345 Metallomics, 2012, 4, 91–100 99 Downloaded on 28/04/2013 18:45:08 Published on 25 October 2011 on http://pubs.rsc.org | doi:10.1039/C1MT00133G View Article Online 28 G F Lin, H Du, J G Chen, H C Lu, W C Guo, H Meng, T B Zhang, X J Zhang, D R Lu, K Golka and J H Shen, Arsenic-related skin lesions and glutathione S-transferase P1 A1578G (Ile105Val) polymorphism in two ethnic clans exposed to indoor combustion of high arsenic coal in one village, Pharmacogenet Genomics, 2006, 16, 863–871 29 K M McCarty, L Ryan, E A Houseman, P L Williams, D P Miller, Q Quamruzzaman, M Rahman, G Mahiuddin, T Smith, E Gonzalez, L Su and D C Christiani, A case-control study of GST polymorphisms and arsenic related skin lesions, Environ Health Global Access Sci Source, 2007, 6, 1–10 30 Y H Wang, M M Wu, C T Hong, L M Lien, Y C Hsieh, H P Tseng, S F Chang, C L Su, H Y Chiou and C J Chen, Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan, Atherosclerosis, 2007, 192, 305–312 31 L I Hsu, A W Chiu, S K Huan, C L Chen, Y H Wang, F I Hsieh, W L Chou, L H Wang and C J Chen, SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan, Toxicol.Appl Pharmacol., 2008, 228, 144–155 32 R Marcos, V Martinez, A Hernandez, A Creus, C Sekaran, H Tokunaga and D Quinteros, Metabolic profile in workers occupationally exposed to arsenic: role of GST polymorphisms, J Occup Environ Med., 2006, 48, 334–341 33 T Agusa, T Kunito, J Fujihara, R Kubota, T B Minh, P T K Trang, A Subramanian, H Iwata, P H Viet and S Tanabe, Contamination by trace elements in groundwater of Vietnam, Biomed Res Trace Elem., 2004, 15, 339–341 34 T Agusa, S Inoue, T Kunito, R Kubota, T B Minh, P T K Trang, A Subramanian, H Iwata, P H Viet and S Tanabe, Widely-distributed arsenic pollution in groundwater in the Red River Delta, Vietnam, Biomed Res Trace Elem., 2005, 16, 296–298 35 T Agusa, T Kunito, J Fujihara, R Kubota, T B Minh, P T K Trang, H Iwata, A Subramanian, P H Viet and S Tanabe, Contamination by arsenic and other trace elements in tube-well water and its risk assessment to humans in Hanoi, Vietnam, Environ Pollut., 2006, 139, 95–106 36 T Agusa, R Kubota, T Kunito, T B Minh, P T K Trang, C Chamnan, H Iwata, P H Viet, T S Tana and S Tanabe, Arsenic pollution in groundwater of Vietnam and Cambodia: a review, Biomed Res Trace Elem., 2007, 18, 35–47 37 T Agusa, T Kunito, T B Minh, P T K Trang, H Iwata, P H Viet and S Tanabe, Relationship of urinary arsenic metabolites to intake estimates in residents of the Red River Delta, Vietnam, Environ Pollut., 2009, 157, 396–403 38 T Agusa, S Inoue, T Kunito, T B Minh, N N Ha, N P C Tu, P T K Trang, H Iwata, P H Viet, B C Tuyen and S Tanabe, Human exposure to arsenic from groundwater in the Red River and the Mekong River Deltas in Vietnam, Int J Environ Stud., 2009, 66, 49–57 39 T Agusa, H Iwata, J Fujihara, T Kunito, H Takeshita, T B Minh, P T K Trang, P H Viet and S Tanabe, Genetic polymorphisms in AS3MT and arsenic metabolism in residents of the Red River Delta, Vietnam, Toxicol Appl Pharmacol., 2009, 236, 131–141 40 T Agusa, H Iwata, J Fujihara, T Kunito, H Takeshita, T B Minh, P T K Trang, P H Viet and S Tanabe, Genetic polymorphisms in glutathione S-transferase (GST) superfamily and arsenic metabolism in residents of the Red River Delta, Vietnam, Toxicol Appl Pharmacol., 2010, 242, 352–362 41 T Agusa, T Kunito, R Kubota, S Inoue, J Fujihara, T B Minh, N N Ha, N P C Tu, P T K Trang, C Chamnan, H Takeshita, H Iwata, B C Tuyen, P H Viet, T S Tana and S Tanabe, Exposure, metabolism, and health effects of arsenic in residents from arsenic-contaminated groundwater areas of Vietnam and Cambodia: A review, Rev Environ Health, 2010, 25, 193–220 100 Metallomics, 2012, 4, 91–100 42 H Iwata, E Y Kim, M Yamauchi, S Inoue, T Agusa and S Tanabe, Chemical contamination in aquatic ecosystems, Yakugaku Zasshi—J Pharm Soc Jpn, 2007, 127, 417–428 43 R Kubota, T Kunito, T Agusa, J Fujihara, I Monirith, H Iwata, A Subramanian, T S Tana and S Tanabe, Urinary 8-hydroxy-2 -deoxyguanosine in inhabitants chronically exposed to arsenic in groundwater in Cambodia, J Environ Monit., 2006, 8, 293–299 44 S Tanabe, Environmental Specimen Bank in Ehime University (es-BANK), Japan for global monitoring, J Environ Monit., 2006, 8, 782–790 45 C H Tseng, A review on environmental factors regulating arsenic methylation in humans, Toxicol Appl Pharmacol., 2009, 235, 338–350 46 E M Leslie, A Haimeur and M P Waalkes, Arsenic transport by the human multidrug resistance protein (MRP1/ABCC1): evidence that a tri-glutathione conjugate is required, J Biol Chem., 2004, 279, 32700–32708 47 C.-H Tseng, Y.-K Huang, Y.-L Huang, C.-J Chung, M.-H Yang, C.-J Chen and Y.-M Hsueh, Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan, Toxicol Appl Pharmacol., 2005, 206, 299–308 48 A L Lindberg, R Kumar, W Goessler, R Thirumaran, E Gurzau, K Koppova, P Rudnai, G Leonardi, T Fletcher and M Vahter, Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms, Environ Health Perspect., 2007, 115, 10811086 49 L Li, E C Ekstroăm, W Goessler, B Loănnerdal, B Nermell, M Yunus, A Rahman, S El Arifeen, L A˚ Persson and M Vahter, Nutritional status has marginal influence on the metabolism of inorganic arsenic in pregnant Bangladeshi women, Environ Health Perspect., 2008, 116, 315–321 50 A L Lindberg, E C Ekstroăm, B Nermell, M Rahman, B Loănnerdal, L A Persson and M Vahter, Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh, Environ Res., 2008, 106, 110–120 51 P Kurttio, H Komulainen, E Hakala, H Kahelin and J Pekkanen, Urinary excretion of arsenic species after exposure to arsenic present in drinking water, Arch Environ Contam Toxicol., 1998, 34, 297–305 52 C Steinmaus, L E Moore, M Shipp, D Kalman, O A Rey, M L Biggs, C Hopenhayn, M N Bates, S C Zheng, J K Wiencke and A H Smith, Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic, J Toxicol Environ Health, Part A, 2007, 70, 159–170, DOI: 10.1080/15287390600755240 53 U K Chowdhury, M M Rahman, M K Sengupta, D Lodh, C R Chanda, S Roy, Q Quamruzzaman, H Tokunaga, M Ando and D Chakraborti, Pattern of excretion of arsenic compounds [arsenite, arsenate, MMA(V), DMA(V)] in urine of children compared to adults from an arsenic exposed area in Bangladesh, J Environ Sci Health, Part A: Toxic/Hazard Subst Environ Eng., 2003, 38, 87–113 54 J S Chung, D A Kalman, L E Moore, M J Kosnett, A P Arroyo, M Beeris, D N Guha Mazumder, A L Hernandez and A H Smith, Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water, Environ Health Perspect., 2002, 110, 729733 55 K Schlaăwicke Engstroăm, K Broberg, G Concha, B Nermell, M Warholm and M Vahter, Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina, Environ Health Perspect., 2007, 115, 599–605, DOI: 10.1289/Ehp.9734 56 I J Letourneau, R G Deeley and S P C Cole, Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein (MRP1/ ABCC1), Pharmacogenet Genomics, 2005, 15, 647–657 This journal is c The Royal Society of Chemistry 2012 ... creatinine To understand the exposure level of As in local people through drinking water, relationships between As concentrations in drinking water and human urine were assessed As shown in Fig... samples with TA concentrations exceeding the guideline value for drinking water5 were 88% and 29%, respectively Considered that As concentration in the drinking water represents close to the real exposure. .. those in filtered water for the houses with the filter system Concentrations of TA in drinking water from HH, TV, LT, and TH are shown in Table The highest As concentration in drinking water was